Led by the University of Delaware, the team will develop new and complementary technologies for achieving and monitoring the removal of host-cell proteins (HCPs) in purification of monoclonal antibodies (mAbs) made by Chinese hamster ovary (CHO) cells.
HCP removal in multiple applications by employing novel LigaGuardTM materials that specifically capture CHO HCPs.
Benchmark and standardize liquid chromatography-mass spectrometry (LC-MS) technology to monitor HCP levels in biomanufacturing
characterize HCP aggregates that contribute to HCP persistence in process streams and hence develop new methods to improve their removal.
This will be accomplished by improving HCP removal in multiple applications by employing novel LigaGuardTM materials that specifically capture CHO HCPs while allowing the mAb product to flow through unbound, characterizing HCP aggregates that contribute to HCP persistence in process streams and develop new methods to improve their removal, and benchmarking and standardizing liquid chromatography-mass spectrometry (LC-MS) technology to monitor HCP levels in biomanufacturing.
Coming soon
Lenhoff, A., Conference Participant, 5.2-133: Modernizing Clearance and Quantification of Host-Cell Proteins in mAb Manufacture, NIIMBL National Meeting, Washington, D.C., June 26, 2025.
Lenhoff, A., Understanding and Mitigating Persistence of CHO Host-Cell Proteins in MAb Bioprocessing, ISPPP 2023 (Intl. Symposium on Separations of Proteins, Peptides and Polynucleotides, Vienna, Austria, November 7, 2023.
Menegatti, S., Mouchahoir, T., Lenhoff, A., Cramer, S., Bill, J., Li, S. X., Xu, X., Tully, T., & Crapanzano, M., Modernizing Clearance and Quantification of Host-Cell Proteins in mAb Manufacture, NIIMBL National Meeting, Washington, DC, June 27, 2024.
Login to the NIIMBL member portal to access additional project information, including presentations, progress updates, reports, and more.
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

University of Delaware
Bristol-Myers Squibb
Chromagenix
Federal Stakeholder: National Institute of Standards and Technology
Genentech, Inc.
Merck Sharp & Dohme LLC
North Carolina State University
Pfizer, Inc.
Rensselaer Polytechnic Institute